Confronto

Epitalon vs. Icatibant

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

307297-39-8

138614-30-9

Peso molecolare

390.35 g/mol

1304.52 g/mol

Emivita

0.3 h

nessun dato

Sequenza

Ala-Glu-Asp-Gly

nessun dato

Meccanismo d'azione

Epitalon

Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.

Icatibant

Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.

Base di evidenze

Evidenza più alta

Studio sull'uomo

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Epitalon	Icatibant
Germania	Non approvato	Su prescrizione
RU	Solo ricerca	—
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Epitalon and Icatibant?: Epitalon is classified as "Ricerca (altro)", while Icatibant is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Epitalon or Icatibant?: The highest available evidence level is "Studio sull'uomo" for Epitalon and "RCT sull'uomo" for Icatibant. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Epitalon and Icatibant in Germany and the United States?: Germania: Epitalon — Non approvato, Icatibant — Su prescrizione. Stati Uniti: Epitalon — Non approvato, Icatibant — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Epitalon

Icatibant

Germania

Non approvato

Su prescrizione

Solo ricerca

—

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Epitalon and Icatibant?

Epitalon is classified as "Ricerca (altro)", while Icatibant is classified as "Ricerca (altro)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Epitalon or Icatibant?

The highest available evidence level is "Studio sull'uomo" for Epitalon and "RCT sull'uomo" for Icatibant. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Epitalon and Icatibant in Germany and the United States?

Germania: Epitalon — Non approvato, Icatibant — Su prescrizione. Stati Uniti: Epitalon — Non approvato, Icatibant — Su prescrizione. These are factual summaries with source and review date on the individual pages.